Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Cambrex Expands High Point, North Carolina, Manufacturing Center

10/15/2021
Pharmaceutical manufacturer, Cambrex Corporation, will invest $30 million at its manufacturing center of excellence in High Point, North Carolina. The project is expected to create 78 jobs in Guilford County.

The company will expand its small batch manufacturing capacity with additional production and laboratory space.

“Cambrex’s mission is to support our pharmaceutical customers in the development and manufacturing of new therapies that improve human health,” said Thomas Loewald, Cambrex CEO. “As a result of our High Point team’s commitment to providing our customers best-in-class technical expertise, innovative chemistry, and engineering solutions, the facility has seen rapid growth in demand for our development and manufacturing services. We are extremely excited about this expansion in North Carolina, which would not have been possible without the support of the State’s leadership and economic development programs, and their focus on nurturing the region’s skilled and diverse workforce.”

A performance-based grant of $200,000 from the One North Carolina Fund will help with Cambrex’s expansion to North Carolina. The One NC Fund provides financial assistance to local governments to help attract economic investment and to create jobs. Companies receive no money upfront and must meet job creation and capital investment targets to qualify for payment. All One NC grants require a matching grant from local governments and any award is contingent upon that condition being met.

“We are excited to celebrate Cambrex’s expansion on National Manufacturing Day,” said Governor Roy Cooper. “When thriving pharmaceutical companies continue manufacturing life-changing medicines in North Carolina, it validates our reputation as a place where life science companies can flourish and do groundbreaking work.”

Cambrex is a leading small molecule company that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With 40 years’ experience, Cambrex serves clients in North America and Europe by providing full-service research, development, and commercial manufacturing.

“The life sciences and manufacturing sectors are major contributors to North Carolina’s economic success,” said North Carolina Commerce Secretary Machelle Baker Sanders. “With the execution of the state’s First in Talent strategic plan, we will continue to develop a skilled, diverse, and inclusive workforce that will help attract and support the growth of innovative manufacturers like Cambrex.”

Joining the North Carolina Department of Commerce and the Economic Development Partnership of North Carolina were key partners in the project that included the North Carolina General Assembly, the North Carolina Community College System, North Carolina Biotechnology Center, GuilfordWorks, Guilford County Economic Development Alliance, High Point Economic Development Corporation, and the City of High Point.

Exclusive Research